VANGELISTA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.320
AS - Asia 1.115
EU - Europa 732
SA - Sud America 194
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.400
Nazione #
US - Stati Uniti d'America 1.272
CN - Cina 393
IE - Irlanda 331
SG - Singapore 318
HK - Hong Kong 176
RU - Federazione Russa 153
BR - Brasile 140
VN - Vietnam 99
FR - Francia 66
GB - Regno Unito 41
DE - Germania 38
IT - Italia 27
CA - Canada 25
IN - India 24
FI - Finlandia 23
AR - Argentina 19
MX - Messico 19
BD - Bangladesh 16
IQ - Iraq 14
ZA - Sudafrica 14
PK - Pakistan 13
CO - Colombia 11
NL - Olanda 11
EC - Ecuador 9
ES - Italia 9
TR - Turchia 9
AT - Austria 8
PL - Polonia 8
JP - Giappone 7
VE - Venezuela 7
MA - Marocco 6
SE - Svezia 6
ID - Indonesia 5
KZ - Kazakistan 5
SA - Arabia Saudita 5
TN - Tunisia 5
PH - Filippine 4
BO - Bolivia 3
CL - Cile 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
NP - Nepal 3
UA - Ucraina 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
AU - Australia 1
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.400
Città #
Dublin 331
Dallas 306
San Jose 211
Hong Kong 174
Singapore 164
Ashburn 152
Boardman 82
Beijing 80
Lauterbourg 56
Los Angeles 53
Shanghai 49
Jacksonville 40
Nanjing 40
Moscow 36
New York 29
Ho Chi Minh City 28
Hanoi 26
The Dalles 24
Helsinki 23
Nanchang 22
Redondo Beach 21
Buffalo 17
Tianjin 16
Princeton 15
Lawrence 13
Frankfurt am Main 12
Hebei 12
Montreal 12
Brooklyn 11
Santa Clara 11
São Paulo 11
Washington 11
Mexico City 10
Nuremberg 10
Orem 10
Phoenix 10
Atlanta 9
Chennai 9
Council Bluffs 9
Johannesburg 9
Shenyang 9
Wilmington 9
Amsterdam 8
Denver 8
Seattle 8
Boston 7
Changsha 7
Jiaxing 7
Warsaw 7
Baghdad 6
Haiphong 6
Hangzhou 6
Rio de Janeiro 6
Tokyo 6
Belo Horizonte 5
Calgary 5
Columbus 5
Falkenstein 5
Imbersago 5
Poplar 5
San Francisco 5
Chongqing 4
Guangzhou 4
London 4
Medellín 4
Medford 4
Milan 4
Mosul 4
New Delhi 4
Rome 4
Secaucus 4
Stockholm 4
Suzano 4
São Bernardo do Campo 4
Amman 3
Ankara 3
Ann Arbor 3
Brasília 3
Caracas 3
Chandler 3
Charlotte 3
Chicago 3
Curitiba 3
Da Nang 3
Dhaka 3
Empalme San Vicente 3
Gangseo-gu 3
Hải Dương 3
Lahore 3
Nairobi 3
Nha Trang 3
Porto Alegre 3
Quận Ba 3
Riyadh 3
Tashkent 3
Tunis 3
Vienna 3
West Jordan 3
Almaty 2
Anyang 2
Totale 2.427
Nome #
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5 78
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments - Candidates for a novel form of specific immunotherapy 77
Calcium-dependent immunoglobulin E recognition of the apo- and calcium- bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7 75
Calcium-binding allergens: From plants to man 74
AllergoOncology – the impact of allergy in oncology: EAACI position paper 72
Bip 1, a monoclonal antibody with specificity for the major birch pollen allergen Bet v 1, modulates IgE binding to the allergen 69
B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy 67
A minimal receptor-Ig chimera of human FcεRI α-chain efficiently binds secretory and membrane IgE 66
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer 65
Staphylococcus aureus infection and persistence in chronic rhinosinusitis: Focus on leukocidin ED 65
A molecular model of type I allergy: Identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcεRI interaction and reacts with receptor-bound IgE 63
Cutting edge: IgE plays an active role in tumor immunosurveillance in mice 63
Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria 62
Purification, biochemical, and immunological characterisation of a major food allergen: Different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin 62
The elastic I-band region of titin is assembled in a "modular" fashion by weakly interacting Ig-like domains 61
Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTRΔF508 60
AllergoOncology: The role of IgE-mediated allergy in cancer 60
An in vitro model for the Allergen-IgE-FcεRI interaction 60
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses 58
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 58
Critical role of the N-loop and β1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 58
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from timothy grass (Phleum pratense) pollen 58
AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper 57
Ultralow Limit Detection of Soluble HER2 Biomarker in Serum with a Fiber-Optic Ball-Tip Resonator Assisted by a Tilted FBG 57
Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis 56
Editorial: CCR5: A receptor at the center stage in infection 55
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides 55
An antitumor cellular vaccine based on a mini-membrane IgE 55
Rational Engineering of a Sub-Picomolar HIV-1 Blocker 55
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1 55
The immunoglobulin-like modules C epsilon 3 and alpha 2 are the minimal units necessary for human IgE-Fc epsilon RI interaction 55
Antitumor IgE adjuvanticity: Key role of FcεRI 54
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy 54
Molecular Characterization of Bip 1, a Monoclonal Antibody That Modulates IgE Binding to Birch Pollen Allergen, Bet v 1 54
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: Molecular, immunological, and structural characterization of the epitope-containing domain 53
NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE 53
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments 53
Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES 52
Functionalized etched tilted fiber Bragg grating aptasensor for label-free protein detection 51
Current progress in the understanding of IgE-FcεRI interaction 50
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 50
Molecular and immunological characterization of carp parvalbumin, a major fish allergen 49
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: Structural basis for calcium-modulated IgE recognition 49
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers 48
NON-ANAPHYLACTIC FORMS OF ALLERGENS AND THEIR USE 48
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 46
Perspectives on Assembling Coronavirus Spikes on Fiber Optics to Reveal Broadly Recognizing Antibodies and Generate a Universal Coronavirus Detector 43
IgE as Adjuvant in Tumor Vaccination 43
Modified microbiota for microbicide drug delivery 43
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 42
Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis 41
Membrane immunoglobulins are stabilized by interchain disulfide bonds occurring within the extracellular membrane-proximal domain 41
The expanding therapeutic perspective of CCR5 blockade 41
In search of a vaccine for mouse allergy: Significant reduction of mus m 1 allergenicity by structure-guided single-point mutations 40
Picomolar detection of thrombin with fiber-optic ball resonator sensor using optical backscatter reflectometry 39
Unreliable measurement of basophil maximum leukotriene release with the Bühlmann CAST 2000 enzyme-linked immunosorbent assay kit 39
Rapid detection of vaccinia virus using biofunctionalized fiber-optic ball-tip biosensors 38
Structural Studies on the Zinc‐endopeptidase Light Chain of Tetanus Neurotoxin 37
Efficient folding of the FcεRI α-chain membrane-proximal domain D2 depends on the presence of the N-terminal domain D1 37
Membrane IgE binds and activates FcεRI in an antigen-independent manner 37
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential 37
Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4 34
Detection of vaccinia virus proteins in wastewater environment using biofunctionalized optical fiber semi-distributed FBG-assisted interferometric probes 33
Fiber-optic semi-distributed Fabry-Perot interferometer for low-limit label-free detection of CCL5 cancer biomarker 32
Proof of principle for a sensitive, real time and label-free detection of poxviruses using optical fiber biosensors 31
Ig modules as discrete structural units to exploit functional and structural aspects of Ig-like receptors 31
Role and redirection of IgE against cancer 25
Totale 3.479
Categoria #
all - tutte 18.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 9 0 0
2021/202232 0 0 0 0 0 0 0 1 2 0 10 19
2022/2023409 22 0 0 0 0 0 0 0 376 3 8 0
2023/2024236 23 8 10 20 24 71 31 10 4 8 5 22
2024/2025747 23 68 1 8 32 23 64 22 206 42 116 142
2025/20261.876 142 174 406 142 229 117 345 39 150 132 0 0
Totale 3.479